BCL9L Antikörper (AA 606-751)
-
- Target Alle BCL9L Antikörper anzeigen
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
Bindungsspezifität
- AA 606-751
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL9L Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Flow Cytometry (FACS), Immunohistochemistry (IHC), Neutralization (Neut)
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of human BCL9L (AA: 606-751) expressed in E. coli.
- Klon
- 1C9G2
- Isotyp
- IgG1
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, ICC: N/A, FCM: 1:200 - 1:400, IHC: N/A
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
- Target
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
- Andere Bezeichnung
- BCL9L (BCL9L Produkte)
- Synonyme
- BCL9-2 antikoerper, DLNB11 antikoerper, B9L antikoerper, BC003321 antikoerper, bcl9-2 antikoerper, BCL9L antikoerper, B-cell CLL/lymphoma 9 like antikoerper, B cell CLL/lymphoma 9-like antikoerper, B-cell CLL/lymphoma 9-like antikoerper, BCL9L antikoerper, Bcl9l antikoerper, bcl9l antikoerper
- Hintergrund
-
Description: BCL9L (B-Cell CLL/Lymphoma 9-Like) is a Protein Coding gene. Among its related pathways are Wnt Signaling Pathways: beta-Catenin-dependent Wnt Signaling and Signaling by Wnt. GO annotations related to this gene include transcription coactivator activity and beta-catenin binding. An important paralog of this gene is BCL9.
Aliases: BCL9-2, DLNB11
- Molekulargewicht
- 157 kDa
- Gen-ID
- 283149
- HGNC
- 283149
- Pathways
- Stem Cell Maintenance
-